Cargando…
Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent ovarian cancer is usually drug-resistant. The morbidity and mortality of ovarian cancer are high worldwide and new methods of diagnosis and therapy are needed. MicroRNAs (miRNAs) are posttranscriptional regulators...
Autores principales: | Banno, Kouji, Yanokura, Megumi, Iida, Miho, Adachi, Masataka, Nakamura, Kanako, Nogami, Yuya, Umene, Kiyoko, Masuda, Kenta, Kisu, Iori, Nomura, Hiroyuki, Kataoka, Fumio, Tominaga, Eiichiro, Aoki, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009316/ https://www.ncbi.nlm.nih.gov/pubmed/24822185 http://dx.doi.org/10.1155/2014/232817 |
Ejemplares similares
-
Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer
por: UMENE, KIYOKO, et al.
Publicado: (2015) -
Current status of molecular-targeted drugs for endometrial cancer (Review)
por: NOGAMI, YUYA, et al.
Publicado: (2013) -
Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
por: Umene, Kiyoko, et al.
Publicado: (2019) -
Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013) -
New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
por: UMENE, KIYOKO, et al.
Publicado: (2013)